Moloney Securities Asset Management, LLC Dynavax Technologies Corp Transaction History
Moloney Securities Asset Management, LLC
- $723 Million
- Q2 2025
A detailed history of Moloney Securities Asset Management, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 10,100 shares of DVAX stock, worth $105,040. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,100
Previous 10,100
-0.0%
Holding current value
$105,040
Previous $130,000
23.08%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
293Shares Held
120MCall Options Held
294KPut Options Held
86.1K-
Black Rock Inc. New York, NY21.9MShares$228 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$185 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$87.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$66.5 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$44.8 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.32B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...